| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.042 | 0.8 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.038 | 0.8 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |